Jiuzhitang Co Ltd (SHE:000989) — Market Cap & Net Worth
Market Cap & Net Worth: Jiuzhitang Co Ltd (000989)
Jiuzhitang Co Ltd (SHE:000989) has a market capitalization of $1.15 Billion (CN¥7.86 Billion) as of August 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #8221 globally and #1875 in its home market, demonstrating a 4.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiuzhitang Co Ltd's stock price CN¥9.18 by its total outstanding shares 855942012 (855.94 Million). See 000989 capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Jiuzhitang Co Ltd Market Cap History: 2015 to 2026
Jiuzhitang Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.55 Billion to $1.15 Billion (-5.49% CAGR).
Jiuzhitang Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiuzhitang Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.42x
Jiuzhitang Co Ltd's market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.61x
Jiuzhitang Co Ltd's market cap is 4.61 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.55 Billion | $871.51 Million | $471.03 Million | 2.93x | 5.41x |
| 2016 | $2.01 Billion | $2.67 Billion | $651.81 Million | 0.75x | 3.08x |
| 2017 | $1.76 Billion | $3.84 Billion | $721.42 Million | 0.46x | 2.44x |
| 2018 | $946.00 Million | $3.16 Billion | $336.48 Million | 0.30x | 2.81x |
| 2019 | $843.50 Million | $3.18 Billion | $192.15 Million | 0.26x | 4.39x |
| 2020 | $829.35 Million | $3.56 Billion | $272.31 Million | 0.23x | 3.05x |
| 2021 | $1.20 Billion | $3.78 Billion | $270.70 Million | 0.32x | 4.43x |
| 2022 | $1.02 Billion | $3.03 Billion | $357.99 Million | 0.34x | 2.84x |
| 2023 | $1.20 Billion | $2.96 Billion | $297.41 Million | 0.41x | 4.04x |
| 2024 | $997.00 Million | $2.37 Billion | $216.20 Million | 0.42x | 4.61x |
Competitor Companies of 000989 by Market Capitalization
Companies near Jiuzhitang Co Ltd in the global market cap rankings as of August 5, 2026.
Key companies related to Jiuzhitang Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #504 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #543 globally with a market cap of $49.47 Billion USD ( CN¥338.09 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #504 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #543 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.47 Billion | CN¥53.00 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.97 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
Jiuzhitang Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Jiuzhitang Co Ltd's market cap moved from $2.55 Billion to $ 1.15 Billion, with a yearly change of -5.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.15 Billion | +5.15% |
| 2025 | CN¥1.09 Billion | +9.67% |
| 2024 | CN¥997.00 Million | -17.09% |
| 2023 | CN¥1.20 Billion | +18.19% |
| 2022 | CN¥1.02 Billion | -15.12% |
| 2021 | CN¥1.20 Billion | +44.52% |
| 2020 | CN¥829.35 Million | -1.68% |
| 2019 | CN¥843.50 Million | -10.83% |
| 2018 | CN¥946.00 Million | -46.16% |
| 2017 | CN¥1.76 Billion | -12.53% |
| 2016 | CN¥2.01 Billion | -21.21% |
| 2015 | CN¥2.55 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Jiuzhitang Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.15 Billion USD |
| MoneyControl | $1.15 Billion USD |
| MarketWatch | $1.15 Billion USD |
| marketcap.company | $1.15 Billion USD |
| Reuters | $1.15 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiuzhitang Co Ltd
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment: Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more